Clinical Trials Related to AstraZeneca

Related studies linked through entity extraction aliases.

Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)

Status: ENROLLING_BY_INVITATION
Phase: PHASE2

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE3

Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.

Status: RECRUITING
Phase: N/A

Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia

Status: COMPLETED
Phase: N/A

Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Status: TERMINATED
Phase: PHASE1

Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone

Status: COMPLETED
Phase: PHASE1

HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada

Status: COMPLETED
Phase: N/A

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.

Status: TERMINATED
Phase: PHASE1

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

Status: RECRUITING
Phase: PHASE3

Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)

Status: RECRUITING
Phase: N/A

Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.

Status: RECRUITING
Phase: N/A

Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Anifrolumab for Hidradenitis Suppurativa

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

Status: COMPLETED
Phase: PHASE4

PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia

Status: RECRUITING
Phase: N/A

A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants

Status: COMPLETED
Phase: PHASE1

Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD

Status: COMPLETED
Phase: N/A

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

Status: RECRUITING
Phase: EARLY_PHASE1

Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4

Status: RECRUITING
Phase: PHASE4

hATTR Polyneuropathy in Russia

Status: COMPLETED
Phase: N/A